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Background: Eupatorium cannabinum L. has long been utilized in traditional medicine, however no information is
available regarding cellular effects of full extracts. Here we assessed the effects of E. cannabinum ethanolic extract
(EcEE) on the colon cancer line HT29. Potential interactions with bisphenol A (BPA) a synthetic phenolic compound
to which humans are generally exposed and a commonly used chemotherapeutic agent, doxorubicin (DOX) were
also evaluated.
Methods: HT29 cells were exposed to different concentrations (0.5 to 50 μg/ml) of EcEE alone or in combination
with BPA or DOX. Cell viability was analyzed through resazurin assay. Gene transcription levels for NCL, FOS, p21,
AURKA and bcl-xl were determined through qRT-PCR. Cytological analysis included evaluation of nuclear and mitotic
anomalies after DAPI staining, immunodetection of histone H3 lysine 9 acetylation (H3K9ac) and assessment of DNA
damage by TUNEL assay.
Results: Severe loss of HT29 cell viability was detected for 50 μg/ml EcEE immediately after 24 h exposure whereas
the lower concentrations assayed (0.5, 5 and 25 μg/ml) resulted in significant viability decreases after 96 h. Exposure
to 25 μg/ml EcEE for 48 h resulted in irreversible cell damage leading to a drastic decrease in cell viability after 72 h
recovery in EcEE-free medium. 48 h 25 μg/ml EcEE treatment also induced alteration of colony morphology, H3K9
hyperacetylation, transcriptional up regulation of p21 and down regulation of NCL, FOS and AURKA, indicating
reduced proliferation capacity. This treatment also resulted in drastic mitotic and nuclear disruption accompanied
by up-regulation of bcl-xl, limited TUNEL labeling and nuclear size increase, suggestive of a non-apoptocic cell death
pathway. EcEE/BPA co-exposure increased mitotic anomalies particularly for the lowest EcEE concentration, although
without major effects on viability. Conversely, EcEE/DOX co-exposure decreased cell viability in relation to DOX for
all EcEE concentrations, without affecting the DOX-induced cell cycle arrest.
Conclusions: EcEE has cytotoxic activity on HT29 cancer cells leading to mitotic disruption and non-apoptotic cell
death without severe induction of DNA damage. Interaction experiments showed that EcEE can increase BPA aneugenic
effects and EcEE synergistic effects with DOX supporting a potential use as adjuvant in chemotherapeutic approaches.Background
Eupatorium cannabinum L., commonly known as hemp-
agrimony is a robust perennial herbaceous plant of the
Asteraceae family and the only species of the Eupator-
ium genus found in Europe occurring also throughout
North Africa and Asia [1]. E. cannabinum has long been* Correspondence: mxdelgado@isa.ulisboa.pt
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article, unless otherwise stated.used for medicinal purposes being referred to by Greeks
and Romans as well by the medieval Persian physician
Aviccena, for what is also known as Eupatorium of Avic-
cena, and later by the Portuguese Renaissance pioneer in
tropical medicine, Garcia da Orta (1563) [2]. Presently,
hemp-agrimnony is used in both Chinese [3] and Indian
[4] traditional medicine as well as in natural medicine in
western countries [5] with very diverse therapeutic indica-
tions including influenza-like illnesses [6], hypertension
[3,4,6] and as an anti-tumour agent [4]. E. cannabinum
extracts has been previously characterized and reveal thed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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as well as several phenolic compounds [9,10].
Sesquiterpenes were found to be a major fraction
(43.3%) of essential oil from E. cannabinum aerial parts
[11], being eupatoriopicrin the main component [7].
Eupatoriopicrin has been associated with induction
DNA damage in Ehrlich ascites tumour [12] as well as
with cytostatic activity and both in vitro and in vivo
tumour growth inhibition properties in Lewis lung car-
cinoma and FIG 26 fibrosarcoma [13].
Pyrrolizidine alkaloids are generally associated with
genotoxicity and tumourigenic activities [14], however
the isomers intermedine and lycopsamine indentified in
E. cannabinum have low genotoxic potency [15] and ly-
copsamine was shown to be non-tumourigenic in rats
[16]. Additionally the phenolic compounds identified in
this plant have been described to have anti-inflammatory
[9], anti-parasitary [17], as well as anti-proliferative ef-
fects in several cell lines [18]. In particular, jaceosidin
cytotoxic effects have been demonstrated in normal and
cancer endometrial cells [19] and hispidulin was shown
to efficiently inhibit growth of gastric cancer cells [20]
and liver carcinoma cells without significant toxic effect
in normal liver cells [21].
Although the effects of specific components of Eupa-
torium cannabinum L. extracts have been described, the
cellular effects of the full extracts have not, until now,
been investigated. Thus, here different concentrations of
Eupatorium cannabinum L. ethanolic extract (EcEE)
were evaluated on the colon cancer cell line HT29.
Moreover we also analyzed its interactions with the syn-
thetic phenolic compound bisphenol A (BPA) as well as
with the chemotherapeutic agent Doxorubicin (DOX).
Human exposure to BPA is considered generalized in the
common population and its adverse health effects are the
focus of intense investigation [22,23]. On the other hand,
DOX is a commonly used chemotherapeutic agent to
which cell resistance can emerge [24,25]. Plant constitu-
ents are a major source of bioactive compounds and sev-
eral plants have been investigated aiming to identify
potential synergistic effects with DOX (reviewed in [26]).
Methods
Eupatorium cannabinum L. ethanolic extract
Eupatorium cannabinum L. (Asteraceae) aerial parts
were collected in the Rossas fields of Arouca village,
Portugal, in August during mass flowering. Formal iden-
tification of plant material was performed by A.P. Paes
from “João de Carvalho e Vasconcellos Herbarium” at
Instituto Superior de Agronomia (Lisboa, Portugal). A
voucher specimen was deposited in the same herbarium
under the number LISI 1503/2013. Plant material was
dried and powdered using a grinder and ethanolic ex-
tract (EcEE) was obtained by soaking the material inabsolute ethanol for 48 h at room temperature with gen-
tle shaking. The extract were filtered and concentrated
under vacuum on a rotary evaporator at 40°C and stored
at −20°C for further use.
Cellular cultures, reagents and treatments
HT29 cells were purchased from European Collection of
Cell Cultures (ECACC, UK) and cultivated in RPMI
medium under standard conditions as previously de-
scribed [27]. Before treatments and experiments HT29,
cells were allowed to stabilize for 24 h in standard
medium and further cultivated in EcEE supplemented
media for 24 h, 48 h or 96 h. Crude ethanolic extract
was dissolved in ethanol to a final work concentration of
50 mg/ml before use and added to the culture media at
four different final concentrations (0.5 μg/ml, 5 μg/ml,
25 μg/ml and 50 μg/ml). Bisphenol A (Sigma-Aldrich)
was freshly diluted in ethanol and added to the culture
media to the final concentration of 1 μg/ml (4.4 μM)
that corresponds to the established Tolerable Daily In-
take (TDI) level of 50 ug/kg BW/day [28,29] considering
an average body weight of 70 Kg and daily consumption
of 3 litres of preformed water. Doxorubicin (DOX)
(AppliChem) was dissolved in water at stock concentra-
tion of 1 mg/ml and added to the culture media to final
concentration of 2.5 μg/ml (4 μM) which corresponds to
a therapeutic dosage [30]. For the combined EcEE/BPA
or EcEE/DOX exposures, cells were pre-exposed to EcEE
for 24 h followed by additional 24 h of simultaneous ex-
posure to EcEE and BPA or EcEE and DOX. Single 24 h
BPA or DOX exposure was carried-out in equivalent cell
cultures. For evaluation of cell recovery capacity after
treatments cells were cultivated for additional 72 h in
standard culture medium. Negative controls were per-
formed for all experiments using cells grown in standard
culture medium as well as cells grown in medium supple-
mented with ethanol at final concentration of 170 μM,
corresponding to the final concentration of ethanol used
as vehicle for all EcEE concentrations as well as for BPA.
Cell viability
Cell viability was evaluated by CellTiter-Blue assay (Pro-
mega) following manufacturer’s instructions. Cells were
plated on 96-well plates at a density of 3.2 × 104 cells/
well and after treatments were incubated for 4 h with
CellTiter-Blue Reagent. Additional negative controls
were performed in the absence of cells to guarantee that
the utilized media did not interfere with fluorescence
readings. Experiments were repeated at least three times
with a minimum of three replicates per experiment.
DAPI staining, TUNEL assay and immunodetection
For cytological analysis cells were grown over glass cov-
erslips coated with 0.2% (v/v) gelatin (Sigma-Aldrich)
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PBS. For evaluation of colony morphology, mitotic index
as well as mitotic and nuclear anomalies cells were DAPI
stained and mounted on glass slides with antifade AF1
(Citifluor). DNA damage assessment with TUNEL assay
(Roche) was performed accordingly to manufacturers’
instructions. Immunodetection of H3K9ac and α-tubulin
was performed in fixed cells as previously described [27]
using the primary antidodies anti-acetyl-histone H3(Lys 9)
(ab10812, Abcam) and anti-α-Tubulin (T9026, Sigma-
Aldrich) detected with FITC or Cy3 conjugated secondary
antibodies. Images were captured using the appropriate
excitation and emission filters and recorded using an epi-
fluorescence microscope Zeiss Axioskop2 equipped with a
Zeiss AxioCam MRc5 digital camera. ImageJ software
(http://rsbweb.nih.gov/ij/) was used for nuclear area mea-
surements. The analysis was performed in the pooled re-
sults of at least two independent experiments with at least
two replicates.
cDNA isolation and real-time quantitative PCR
Transcriptional analysis was performed by quantitative
real-time PCR (qRT-PCR) for the proliferation-associated
genes nucleolin (NCL), FOS and p21, for the cell cycle re-
lated gene AURKA, and the anti-apoptotic gene bcl-xl.
The specific primers utilized are listed in Table 1, GAPDH
and β-actin were used as control genes [27,31]. Total
RNA was extracted from trypsinized cells with the RNA-
queous Kit (Invitrogen) following manufacturers’ instruc-
tions. 3 μg of total RNA was utilized for RNase free
DNase digestion (RQ1 RNase free DNase, Promega) and
first strand cDNA synthesis was completed with random
primers (DYNAmo cDNA syntesis Kit, Thermo Scientific).
The resulting cDNA was utilized for qRT-PCR with Sso-
Fast Eva Green Supermix (BioRad) utilizing the following
conditions: 95°C for 3 min, 35 cycles (95°C for 30 s, 55°C
for 30 s, 72°C for 40 s), and 72°C for 5 min. Control PCRs
were also performed with total RNA prior to cDNA syn-
thesis as well as for all primer combinations without tem-
plate. Experiments were repeated at least three times with
at least three replicates per cell treatment/primer combin-
ation in each experiment. Since no significant differencesTable 1 Primers used for qRT-PCR
Sequence Accession no. Forward prim
p21 [31] NM_000380 CTGGAGACTC
AURKA [27] NM_003600 GCTGGAGAGC
FOS [31] NM_005252 AGGAGAATCC
bcl-xl [31] NM_001191.2 TTACCTGAATG
NCL [31] NM_005381 CCTTCTGAGGA
GAPDH [27] NM_002046 GAGTCAACGG
β-actin [31] NM_001101 GGTCATCTTCTwere detected between the two reference genes, thresh-
old cycles (Ct) of the target genes were equilibrated with
the mean Ct of GAPDH and β-actin genes to calculate
ΔCt (ΔCt = Ct target – mean Ct GAPDH:β-actin). Gene ex-
pression levels were analyzed by calculating ΔΔCt (ΔΔCt =
ΔCt treatment – mean ΔCt control). Results are presented as
log2 of the mean fold change (2-ΔΔCt) ± standard deviation.Statistical analysis
Student’s t test was used for statistical analysis of gene
transcription, cell viability, nuclear area and nuclear
fragmentation. No significant differences were detected
between control and vehicle for all parameters analysed,
and results are shown in relation to control. GraphPad
Prism 6 software was used for determination of IC50
values.Results
E. cannabinum ethanolic extract decreases HT29 cell
viability
Assessment of cell viability was performed to test poten-
tial cytotoxic effects of E. cannabinum ethanolic extract
(EcEE) on HT29 cells. For this, CellTiter-Blue assay was
utilized and effects of different concentrations of EcEE
(0.5 μg/ml, 5 μg/ml, 25 μg/ml and 50 μg/ml) were evalu-
ated after 24 h, 48 h and 96 h of exposure (Figure 1-A).
The higher EcEE concentration (50 μg/ml) resulted in a
severe decrease of cell viability after 24 h exposure and
complete loss of viability at subsequent time points ana-
lyzed (48 h and 96 h). On the other hand, no decrease in
cell viability was detected after 24 h or 48 h for the
lower EcEE concentrations, and a slight increase in fluor-
escence was observed after 24 h and 48 h for 25 μg/ml
EcEE. However, significant decreases in cell viability were
detected for the three lower EcEE concentrations after
96 h of exposure, and particularly for 25 μg/ml EcEE
(−18.89%, −14.55% and −73.25% for 0.5 μg/ml, 5 μg/ml
and 25 μg/ml, respectively). Taken together, these results
indicate more severe effects after prolonged exposure.
This is further shown by IC50 values of 46.75, 44.64 and








Figure 1 EcEE affect cell viability and proliferation. (A) Cell viability after 24 h, 48 h and 96 h of exposure to distinct concentrations of EcEE and
(B) after 72 h recovery in EcEE-free medium following 24 h and 48 h treatments. Results are presented as percentage over control, **p < 0.0001 and
*p < 0.01. (C) NCL, FOS and p21 differential transcription after 48 h exposure to distinct EcEE concentrations. Results are shown as mean log2 fold
change (2-ΔΔCt) ± standard deviation in relation control, *p < 0.0001. (D) DAPI stained HT29 colonies after 48 h in control medium and medium
supplemented with EcEE 5 μg/ml or EcEE 25 μg/ml. All images have identical magnification, bar = 50 μm.
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ure cell viability was also evaluated after 72 h of recovery
in standard culture media (Figure 1-B) and revealed a se-
vere decrease exclusively for 48 h exposure to 25 μg/ml
EcEE (−75.59%).
To better understand the effects of EcEE immediately
after 48 h exposure, gene transcription analysis was car-
ried out for three proliferation-associated genes, namely
nucleolin (NCL), p21 and FOS (Figure 1-C). Similarly to
the cell viability results, no significant differences in
transcription levels were detected after 48 h exposure to
EcEE concentrations equal to or lower than 5 μg/ml.
Conversely, 25 μg/ml EcEE exposure resulted in signifi-
cant differences in mRNA levels of all three genes, cor-
responding to down regulation of both NCL and FOS
(Log2 fold change = −0.813 ± 0.248 and −0.741 ± 0.078,
respectively), and up regulation of p21 (Log2 fold change =
1.393 ± 0.128). Evaluation of colony morphology was per-
formed immediately after EcEE treatments by DAPI stain-
ing. Again, significant alterations in colony morphology
were detected after exposure to 25 μg/ml EcEE for 48 h,
evident as cells being more dispersed and showing a flat-
tening of cellular aggregates in comparison to controlswith no detectable effect for 5 μg/ml EcEE (Figure 1-D) or
0.5 μg/ml EcEE (not shown).
E. cannabinum ethanolic extract induces alterations in
nuclear structure and mitotic disruption
A detailed cytological analysis was performed for 0.5 μg/ml,
5 μg/ml and 25 μg/ml EcEE concentrations after 48 h of
exposure and again significant nuclear alterations were
observed exclusively for 25 μg/ml EcEE (Figure 2-A). This
was obvious as the prominent occurrence of micronuclei
and highly condensed nuclei (pyknosis) scattered through-
out cell aggregates as well as fragmented nuclei (karyor-
rhexis), revealing irreversible nuclear damage. In addition,
TUNEL assay showed that induction of DNA breaks also
occurred after 48 h exposure to 25 μg/ml EcEE treatments
although at a much lower level than nuclear abnormal-
ities, as many of the abnormal nuclei were not TUNEL
positive and in positive nuclei labeling was sparse
(Figure 2-B). For the two lower EcEE concentrations (0.5
and 5 μg/ml) no TUNEL positive nuclei were detected
(not shown) as observed for control. Importantly, qRT-
PCR transcriptional analysis of the anti-apoptotic bcl-xl
gene revealed that EcEE exposure induced a significant up
Figure 2 Nuclear organization is disrupted after 48 h of exposure to EcEE 25 μg/ml. (A) DAPI stained HT29 interphase cells. Nuclear
anomalies, namely pyknosis (arrow), micronuclei (open arrow head) and karyorrhexis (arrow head) are detectable only for 25 μg/ml EcEE. The lack
of effects induced by EcEE lower concentrations is exemplified by 5 μg/ml EcEE. (B) TUNEL positive nuclei (arrow) with sparse labeling are
detectable for 25 μg/ml EcEE. (C) bcl-xl differential expression after 48 h exposure to distinct EcEE concentrations. Results in are shown as the
mean log2 fold change (2-ΔΔCt) ± standard deviation in relation control, **p < 0.0001 and *p < 0.01. (D) DAPI staining (blue) and α-tubulin
immunodetection (red in merged images at the bottom) of interphase cells after 48 h in control or 25 μg/ml EcEE. (E) Immunodetection of
H3K9ac after 48 h in control or EcEE 25 μg/ml supplemented medium. Within each experiment all images have identical magnification,
bar = 5 μm.
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change = 0.528 ± 0.243) but also at 5 μg/ml, although to a
lesser extent (Log2 fold change = 0.158 ± 0.067) (Figure 2-C).
Quantification of the nuclear area of non-pyknotic and
non-fragmented DAPI stained nuclei showed a significant
increase in this parameter in relation to control for cells
exposed to 25 μg/ml EcEE but not to the lower EcEE con-
centrations (not shown). The increment in nuclear area
after the 48 h exposure to 25 μg/ml EcEE corresponded in
average to 48.8% (n > 70 for each growth condition, p <
0.0001 for 25 μg/ml EcEE in relation to control) and was
accompanied by an evident increase in cellular area re-
vealed by α-tubulin immunodetection (Figure 2-D). More-
over, evident chromatin enrichment in histone H3
acetylated on lysine 9 (H3K9ac) was detected also for 48 h
25 μg/ml EcEE (Figure 2-E) whereas no alteration was ob-
served for either 0.5 μg/ml or 5 μg/ml EcEE (not shown).
The effects of exposure to EcEE were further evaluated
on mitotic cells after DAPI staining. No significant vari-
ation was observed in the mitotic index between control,vehicle and EcEE independently of the concentration
assayed (varying between 4.57 and 5.94). On the other
hand, although mitotic anomalies, particularly multi-
polar metaphases and anaphases, are a common feature
of HT29 cells and therefore observed both in control
and vehicle (6.67% and 11.76% after 24 h; 6.38% and
10.67% after 48 h, for control and vehicle respectively),
the percentage of abnormal mitosis increased after ex-
posure to all EcEE concentrations (Figures 3-A and B).
Although a slight increase of abnormal mitosis was
already detectable for 0.5 μg/ml EcEE, this effect was
greater for 5 μg/ml EcEE (41% and 44% after 24 h or 48 h,
respectively). After exposure to 25 μg/ml EcEE, most mi-
totic cells presented abnormalities (80% and 63% after 24
and 48 h, respectively). Although the frequency of abnor-
mal mitosis was greater after 24 h at the higher EcEE con-
centration, these results clearly indicate that EcEE induces
mitotic disruption in a dose dependent manner. Interest-
ingly, qRT-PCR analysis revealed a significant down regu-
lation of AURKA (Log2 fold change = −0.938 ± 0.146), a
Figure 3 EcEE exposure induces mitotic disruption. (A) DAPI stained abnormal mitotic cells after EcEE exposure showing (i) defective
chromosome congression, (ii) tripolar and (iii) tetrapolar metaphases and (iv) tripolar anaphase with chromosome bridges, bar = 5 μm. (B) Percentage
of abnormal mitosis after 24 h and 48 h exposure to distinct concentrations of EcEE; the total number of mitotic cells scored and utilized to calculate
the percentage of abnormal mitosis is shown in brackets. (C) AURKA differential transcription after exposure to 48 h of EcEE. Results are shown as the
mean log2 fold change (2-ΔΔCt) ± standard deviation in relation control, *p < 0.0001.
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segregation (Figure 3-C).
E. cannabinum ethanolic extract increases Bisphenol A
induced mitotic disruption
Interactions between EcEE and the environmental pollu-
tant BPA at reference level (1 μg/ml) were evaluated. Co-
exposure to EcEE and BPA did not affect cell viability im-
mediately after treatments, as no significant differences
were detected in relation to control (Figure 4-A). After
72 h recovery in standard medium, a severe decrease inFigure 4 EcEE interacts with BPA at reference level. (A) Cell viability aft
subsequent 72 h recovery in standard medium. Results are presented as pe
after 48 h culture in standard medium (control) or medium supplemented
combination with BPA. The total number of mitotic cells scored and utilized tcell viability (−93.48%) was exclusively observed for 25 μg/ml
EcEE/BPA (Figure 4-A) which was even greater than that
observed for 25 μg/ml EcEE alone (Figure 1-B).
Cytological evaluation of mitotic disruption after DNA
DAPI staining (Figure 4-B) revealed that BPA exposure
alone increased the level of mitotic anomalies to 20.5%.
Interestingly, a stronger effect of BPA co-exposure was
observed for the lowest EcEE concentration assayed
(0.5 μg/ml), which resulted in 41% of abnormal mitosis
(Figure 4-B) compared to 25% observed for EcEE alone
(Figure 3-B). In contrast, no evident effect of BPA waser co-exposure to BPA (1 μg/ml) and distinct EcEE concentrations and
rcentage over control, *p < 0.001. (B) Percentage of mitotic anomalies
with ethanol (vehicle), BPA or EcEE at distinct concentrations in
o calculate the percentage of abnormal mitosis is shown in brackets.
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dent as an identical level of 44% for 5 μg/ml EcEE alone
or in combination with BPA. Co–exposure to the higher
EcEE concentration (25 μg/ml) and BPA resulted in a
particular high level of mitotic anomalies (75%), al-
though the difference in relation to EcEE alone (63%)
was smaller than that observed for the lower EcEE
concentrations.
Cytotoxic effects of Doxorubicin are enhanced by
E. cannabinum
Potential interactions between different concentrations
of EcEE and the chemotherapeutic drug doxorubicin
(DOX) at a therapeutic concentration of 2.5 μg/ml were
investigated. Immediately after exposure, DOX alone
resulted in a slight decrease in cell viability (−4.15%)
(Figure 5-A). Interestingly, the loss of cell viability was
significantly more pronounced after co-exposure to
EcEE/DOX for all EcEE concentrations (−10.03%, −19.88%
and −18.67% for 0.5 μg/ml, 5 μg/ml and 25 μg/ml, respect-
ively) (Figure 5-A) contrasting with the lack of effects
observed for 48 h exposure to EcEE alone (Figure 1-A).
Recovery experiments showed that the effects of both
DOX and 25 μg/ml EcEE/DOX have long lasting negative
effects on viability, apparent as prominent decreases in
cell viability after 72 h recovery in standard medium in re-
lation to what was observed immediately after exposure
(Figure 5-A). After recovery, EcEE 25 μg/ml/DOX expos-
ure resulted in an even more pronounced loss of cell
viability (−93.95%) than that observed for exposure to
25 μg/ml EcEE alone (Figure 1-B). Conversely, for the
lower EcEE concentrations, no significant differences were
detected between exposure to DOX alone and in combin-
ation with EcEE (Figure 1-B).Figure 5 EcEE has synergistic effects with DOX at a therapeutic dose.
concentrations and subsequent 72 h recovery in standard medium. Results
relation to DOX alone is indicated by horizontal brackets, **p < 0.0001 and
DOX illustrating the occurrence of (i) micronuclei (arrow head) and pyknot
(C) Percentage fragmented nuclei after exposure to EcEE 25 μg/ml or DOX
shown in brackets, **p < 0.0001 and *p < 0.03 in relation to EcEE 25 μg/mlCytological analysis after DAPI staining showed a
complete absence of cells at mitosis after exposure to
DOX alone or in combination to EcEE, independently of
the EcEE concentration. Conversely, both pyknotic cells
and fragmented nuclei were observed after exposure to
DOX alone or in combination to EcEE (Figure 5-B).
Since identical nuclear alterations were also observed
after single exposure to 25 μg/ml EcEE (Figure 2-E), the
levels of nuclear fragmentation were compared between
single exposure to 25 μg/ml EcEE or DOX alone and the
combination of both (Figure 5-C). The results revealed
that the induction of nuclear fragmentation is signifi-
cantly higher for 25 μg/ml EcEE/DOX combined expos-
ure (20.28%) than for either DOX (7.63%) or 25 μg/ml
EcEE (8.89%) alone.
Discussion
Eupatorium cannabinum L. is a commonly utilized plant
for alternative and/or complementary medicine treat-
ments [6] including as an anticancer agent [4]. Although
cellular effects of particular phytochemicals known to be
present in E. cannabinum have been previously de-
scribed, to our knowledge this is the first study that eval-
uates the cytotoxic potential of E. cannabinum extracts
on human cancer cells. Here we demonstrated that E.
cannabinum ethanolic extract (EcEE) has cytotoxic ef-
fects on HT29 colon cancer cells in a time and dose
dependent manner. IC50 were similar after 24 and 48 h
(46.75 and 44.65 μg/ml, respectively) but considerably
lower (13.38 μg/ml) after 96 h of exposure. Cytotoxic ac-
tivity has also been demonstrated for extracts from other
Eupatorium species. For E. perfoliatum ethanolic extract,
IC50 values between 12 and 14 μg/ml were obtained after
24 h exposure in three distinct mammalian cell lines(A) Cell viability after co-exposure to DOX (2.5 μg/ml) and distinct EcEE
are presented as percentage over control, the level of significance in
*p < 0.01. (B) DAPI stained cell after co-exposure to EcEE 25 μg/ml/
ic nuclei (arrow) and (ii) fragmented nuclei (arrows), bar = 5 μm.
alone and the combination of both. Total number of cells analyzed is
or DOX alone.
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fect was also observed for E. odoratum ethyl acetate
extract (IC50 of 65.72, 83.88 μg/ml and 92.84 μg/ml for 24,
48 and 72 h, respectively) while for acetone extract higher
IC50 values were obtained but without a direct correlation
with exposure time (133.9, 163.0 and 147.8 μg/ml for 24,
48, and 72 h respectively) [33]. The immediate cytotoxicity
observed here for EcEE is lower than that obtained for E.
perfoliatum ethanolic extract and higher than that of ethyl
acetate or acetone extracts from E. odoratum. Interest-
ingly the time dependent increase in cytotoxicity of EcEE
was only detected for the longer exposure time (96 h).
Moreover, a deferred effect on cell viability was detected
after 48 h exposure to EcEE at 25 μg/ml. This was also as-
sociated with disruption of cell colony three-dimensional
arrangement, a generalized increase in nuclear area and
H3K9 hyperacetylation. Relevantly, gene transcription
analysis revealed a significant reduction in the mRNA
levels of FOS, which encodes for a nuclear protein from
AP-1 transcription factor complex, and nucleolin (NCL)
the most profuse non-ribosomal protein of the nucleolus.
Both FOS and nucleolin are involved in the regulation of
cell proliferation [34,35] as their decreased expression has
been related with reduced proliferation capacity of cancer
cells including colon cancer cell lines [36,37]. On the
other hand, exposure to EcEE (25 μg/ml, 48 h) also re-
sulted in the up regulation of p21, a cyclin-dependent kin-
ase inhibitor which is a major regulator of the cell cycle
[38]. It was previously shown that histone hyperacetyla-
tion induces p21 over expression [39]. In colon cancer
cells inhibition of histone deacetylation results in both up
regulation of p21 [40], and induction of G2/M cell cycle
arrest [41]. Relevantly, cell reduction capacity depends on
the cell cycle being higher at G2/M [42]. Considering that
the cell viability assay used is based on the resazurin re-
duction and that overall our results were incompatible
with EcEE induction of cell proliferation, the slight and
transient augment of fluorescence detected after 24 h and
48 h of exposure to 25 μg/ml EcEE was also suggestive of
cell arrest at G2 or M. Moreover, the increase of abnormal
mitotic cells after exposure to EcEE is also suggestive of a
mitotic block. This phenotype was accompanied by a sig-
nificant down regulation of Aurora A transcription, which
is consistent with previous results showing that decreased
Aurora A levels are associated with mitotic catastrophe
and consequent cell death [43]. Induction of cell death
after 48 h exposure to 25 μg/ml was evident by the prom-
inent occurrence of pyknotic and fragmented nuclei, char-
acteristic of both apoptotic as well as necrotic cells, and
supports the marked loss in cell viability observed after re-
covery. This was moreover associated with transcriptional
up regulation of the anti-apoptotic gene bcl-xL suggesting
a non-apoptotic cell death pathway [44] which is also sup-
ported by limited occurrence of DNA breaks. Theseobservations together with the increase in cell size is com-
patible with a necrotic cell death or necroptosis, a process
which acts as backup death-inducing mechanism when
apoptosis is inhibited [45].
Cytostatic activity was previously described for com-
pounds identified in E. cannabinum extracts, namely the
sesquiterpene eupatoriopicrin [7] and the flavonoids
centaureidin, jaceosidin and hispidulin [10]. Severe de-
crease of tumour cell survival in vitro was associated
with eupatoriopicrin concentrations ranging from 1–
10 μg/ml [12,13] which was correlated with induction of
DNA damage [12]. Also, anti-proliferative effects on dis-
tinct cancer cell lines have been described for centaurei-
din concentrations below 1 μg/ml [18] as well as for
jaceosidin in the concentration range of 20–50 μg/ml
[19] and hispidulin for 4–30 μg/ml [21]. Relevantly, both
jaceosidin [19] and hispidulin [20] effects were associ-
ated with increased p21 expression. The results obtained
here indicate that the anti-proliferative potency of EcEE
is similar to that observed for some of its individual con-
stituents such as eupatoriopicrin, jaceosidin and hispidu-
lin, albeit without marked induction of DNA damage
and therefore suggesting a combined action of distinct
compounds.
Importantly, EcEE combined exposures with DOX at
therapeutic concentration resulted in a clear enhancement
of cytotoxic effects, evident as combined treatments sig-
nificantly decreasing HT29 cell viability immediately after
exposure, even for the lower EcEE concentration that per
se did not affect cell viability. This was accompanied by in-
creased nuclear fragmentation and reduced cell survival
after recovery resulting in almost total loss of cell viability.
DOX is a commonly utilized antineoplastic drug that acts
in tumour cells by induction of apoptosis [46]. Neverthe-
less different types of cell death can occur simultaneously,
independently or through partially common pathways
(reviewed in [45]). The severe decrease in cell viability ob-
served after combined exposure to DOX and EcEE can
thus result from induction of distinct cell death mecha-
nisms. On the other hand therapeutic concentrations of
DOX induces cell arrest at G2/M and/or G1/S check-
points [47,48]. The results obtained show that EcEE does
not counteract DOX-induced cell cycle arrest. Consider-
ing that DOX acts by induction of apoptosis [46] to which
cell resistance can emerge [24,25] our data substantiates
potential adjuvant EcEE properties in chemotherapeutic
approaches [49].
On the other hand, no immediate effect on cell viabil-
ity was associated with co-exposure to EcEE and the
synthetic phenolic compound BPA. However, cell recov-
ery capacity after 48 h exposure to 25 μg/ml EcEE de-
creased by the presence of BPA. Additionally, EcEE/BPA
combined exposures resulted in increased mitotic anomal-
ies in relation to either BPA or EcEE alone for 25 μg/ml
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an aneugenic chemical [50] capable of interfering with cell
division mechanisms even at very low concentrations [27].
Nonetheless BPA is widely used in a variety of consumer
products leading to a generalized human exposure al-
though its risks remain highly controversial [23]. The
present results raise the possibility that adverse BPA ef-
fects could be enhanced by interactions with other chemi-
cals, an aspect that remains largely unknown and has
barely been addressed.
Conclusions
E. cannabinum has been utilized as a medicinal plant for
alternative and/or complementary medicine, however
the effects or the mode of action of full extracts have
not been evaluated at the cellular level. The present
work demonstrates that E. cannabinum ethanolic extract
has potent cytotoxic activity against HT29 colon cancer
cells associated with mitotic disruption and cell death
without marked evidences of DNA damage. Relevantly
E. cannabinum extract exhibits synergistic effects with
doxorubicin in the induction of HT29 cell death indicat-
ing its potential use in alternative or complementary
therapeutic strategies. On the other hand, the results
show also that E. cannabinum can increase aneugenic
effects of the environmental pollutant BPA, drawing at-
tention to the possibility that BPA adverse effects may
be potentiated by interaction with other chemicals.
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